Samil Pharm - Asset Resilience Ratio

Latest as of September 2022: 0.00%

Samil Pharm (000520) has an Asset Resilience Ratio of 0.00% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩5.80 Million

≈ $3.93K USD Cash + Short-term Investments

Total Assets

₩288.86 Billion

≈ $195.76 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2021)

This chart shows how Samil Pharm's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Samil Pharm to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Samil Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000520 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩5.80 Million	0.0%
Total Liquid Assets	₩5.80 Million	0.00%

Asset Resilience Insights

Limited Liquidity: Samil Pharm maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Samil Pharm Industry Peers by Asset Resilience Ratio

Compare Samil Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Samil Pharm (2011–2021)

The table below shows the annual Asset Resilience Ratio data for Samil Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	4.98%	₩11.27 Billion ≈ $7.64 Million	₩226.40 Billion ≈ $153.43 Million	+4.35pp
2020-12-31	0.63%	₩1.20 Billion ≈ $813.22K	₩191.66 Billion ≈ $129.89 Million	-6.46pp
2019-12-31	7.09%	₩13.03 Billion ≈ $8.83 Million	₩183.87 Billion ≈ $124.61 Million	+1.68pp
2018-12-31	5.41%	₩8.00 Billion ≈ $5.42 Million	₩147.95 Billion ≈ $100.26 Million	+3.43pp
2016-12-31	1.98%	₩2.00 Billion ≈ $1.36 Million	₩101.00 Billion ≈ $68.44 Million	-0.03pp
2015-12-31	2.01%	₩2.00 Billion ≈ $1.36 Million	₩99.31 Billion ≈ $67.30 Million	-7.22pp
2014-12-31	9.23%	₩10.00 Billion ≈ $6.78 Million	₩108.29 Billion ≈ $73.39 Million	+9.18pp
2012-12-31	0.05%	₩55.00 Million ≈ $37.27K	₩111.00 Billion ≈ $75.22 Million	-0.32pp
2011-12-31	0.37%	₩443.46 Million ≈ $300.53K	₩121.20 Billion ≈ $82.14 Million	--

pp = percentage points

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$89.20 Million

₩131.62 Billion KRW

Market Cap Rank

#19532 Global

#949 in Korea

Share Price

₩6200.00

Change (1 day)

+6.35%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13